NCT06119711

Brief Summary

Rationale: A significant proportion of patients admitted to the Intensive Care Unit (ICU) is unable to fully recover, even when the initial cause of their illness has been treated. Inadequate dietary intake prior to admission and during the recovery phase may leave patients in a frail physical state, limiting rehabilitation potential. Commonly used methods to assess nutritional intake and nutritional status are highly impacted by various disease-related confounders and reporting bias. We hypothesise that a combined assessment of biomarkers in plasma and urine may provide a more accurate overview of nutritional status at ICU-admission. Objective: Main: Assess nutrition-related biomarkers in plasma and urine samples at ICU admission Secondary: Identify the number of micronutrient deficiencies at ICU admission Compare biomarker profile and dietary intake of short and long-stay ICU patients at baseline Compare subjective dietary intake, nutritional status and muscle thickness between patients with and without micronutrient deficiencies at baseline Study design: Observational study Study population: Adult patients admitted to the ICU. Two groups will be recruited: patients with a short length of stay (\<48 hours) and patients with a longer length of stay (≥48 hours). Main study parameters: Biomarker status in blood and urine at ICU admission. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: In addition to standard care ICU treatment, the following measurements will be performed:

  • Within 24 hours after admission blood and urine samples will be collected from existing venous line and urinary catheter
  • Within 72 hours an ultrasound measurement of the upper leg will be performed.
  • During ICU stay, when the patient is capable to do so, they will be asked to complete a retrospective dietary intake assessment. The risks and negative effects of these tests are limited. However, this study asks for a time investment and physical and mental effort of the patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2023

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

July 3, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 3, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 7, 2023

Completed
Last Updated

November 21, 2024

Status Verified

March 1, 2024

Enrollment Period

5 months

First QC Date

July 3, 2023

Last Update Submit

November 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of biomarker deficits at ICU admission

    Total number of biomarker deficts at ICU admission, based on data collected within 24 hours after admission on: Markers general health: haemoglobin (Hb), mean corpuscular volume (MCV), glucose, c-reactive protein (CRP), thyroid stimulating hormone (TSH), creatinine + glomerular filtration rate (eGFR), alanine aminotransferase (ALAT), urea, albumin, total protein, lipid profile Micronutrients: potassium, calcium, sodium, vit B11, vit B1, vit B6, vit B12, vit D, Vit C, ferritin, magnesium, chloride, phosphorus

    at ICU admission

Secondary Outcomes (2)

  • Dietary intake

    at ICU admission

  • Physical health

    at ICU admission

Other Outcomes (2)

  • Patient characteristics

    at ICU admission

  • Clinical data

    at ICU admission

Study Arms (2)

Short stay

Patients admitted to the ICU with a need for mechanical ventilation of less than 48 hours

Other: No intervention

Long stay

Patients admitted to the ICU with a need for mechanical ventilation of 48 hours or more

Other: No intervention

Interventions

No intervention

Long stayShort stay

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients admitted to the ICU within six months after start of the study (March-August 2023) will be asked for consent to participate in this study. A maximum of 50 'short stay' (\<48 hours admitted) patients will be included. These patients will only participate in the baseline measurements. Patients that are eligible for the standard post-ICU outpatient clinic at three months (≥48 hours admitted/ventilated) will be invited for additional study measurements at the standard care outpatient visit at three months after admission.

You may qualify if:

  • Age: 18 years and above.

You may not qualify if:

  • Not proficient in speaking and/or understanding Dutch
  • Comorbidity highly affecting gut absorption (e.g. post-bariatric surgery)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical Centre Leeuwarden

Leeuwarden, 8934AD, Netherlands

Location

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 3, 2023

First Posted

November 7, 2023

Study Start

May 8, 2023

Primary Completion

October 3, 2023

Study Completion

October 3, 2023

Last Updated

November 21, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations